ArticleDiscover oncology2026

Identification of hsa-miR-144-3p as a novel immunotherapeutic target for glioblastoma based on disulfidptosis-related analysis.

Mengda Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.